Literature DB >> 12215823

Interleukin genetic variants and the risk of renal failure in infants with infection.

András Treszl1, Péter Tóth-Heyn, István Kocsis, András Nobilis, Agnes Schuler, Tivadar Tulassay, Barna Vásárhelyi.   

Abstract

Systemic infection is a major risk factor for the development of neonatal acute renal failure (ARF). We investigated whether genetic polymorphisms of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-6, and IL-10 genes leading to a more intense inflammatory response might predispose very low birth weight (VLBW) infants to the development of ARF in severe infection. The medical records of 92 VLBW newborns (birth weight under 1,500 g) with systemic infection were analyzed. ARF developed in 38 infants during the 1st postnatal week, while 54 neonates exhibited normal renal function. The variants of TNF-alpha, IL-1beta, IL-6, and IL-10 genes were determined from dried blood samples with polymerase chain reaction and restriction fragment length polymorphism methods. The allele frequencies did not differ in ARF and in non-ARF babies, while the (TNF-alpha /IL-6) AG/GC or AG/CC haplotypes were more often present in ARF (26% vs. 6%, P<0.01). The single presence of TNF-alpha, IL-1beta, IL-6, and IL-10 variants does not influence the development of ARF, but the constellation of TNF-alpha and IL-6 genetic variants is associated with ARF. We hypothesize that the simultaneous presence of these polymorphisms might lead to an enhanced inflammatory response in the kidneys in babies with infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12215823     DOI: 10.1007/s00467-002-0935-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

Review 1.  Impact of common genetic variation on neonatal disease and outcome.

Authors:  David Harding
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-09       Impact factor: 5.747

2.  Effect of TNF-α and IL-1β genetic variants on the development of myocardial infarction in Turkish population.

Authors:  Umit Zeybek; Bahar Toptas; Zeynep Ermis Karaali; Mehmet Kendir; Bedia Cakmakoglu
Journal:  Mol Biol Rep       Date:  2011-03-06       Impact factor: 2.316

Review 3.  Novel aspects of pharmacological therapies for acute renal failure.

Authors:  Ulrich Kunzendorf; Michael Haase; Lars Rölver; Anja Haase-Fielitz
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

4.  Genetic polymorphisms and risk for acute renal failure in preterm neonates.

Authors:  Barna Vásárhelyi; Péter Tóth-Heyn; András Treszl; Tivadar Tulassay
Journal:  Pediatr Nephrol       Date:  2004-12-31       Impact factor: 3.714

Review 5.  Management of acute kidney injury in children: a guide for pediatricians.

Authors:  Sharon P Andreoli
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 6.  Searching for genes that matter in acute kidney injury: a systematic review.

Authors:  Jonathan C T Lu; Steven G Coca; Uptal D Patel; Lloyd Cantley; Chirag R Parikh
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

Review 7.  AKI and Genetics: Evolving Concepts in the Genetics of Acute Kidney Injury: Implications for Pediatric AKI.

Authors:  Kathy Lee-Son; Jennifer G Jetton
Journal:  J Pediatr Genet       Date:  2015-08-13

8.  Association of interleukin 1beta gene (+3953) polymorphism and severity of endometriosis in Turkish women.

Authors:  Rukset Attar; Bedia Agachan; Ozlem Kucukhuseyin; Bahar Toptas; Erkut Attar; Turgay Isbir
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

Review 9.  Emerging concepts in acute kidney injury following cardiac surgery.

Authors:  Christopher Hudson; Jordan Hudson; Madhav Swaminathan; Andrew Shaw; Mark Stafford-Smith; Uptal D Patel
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2008-11-19

Review 10.  Acute kidney injury in children.

Authors:  Sharon Phillips Andreoli
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.